Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             42 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A dietary pattern derived to correlate with estrogens and risk of postmenopausal breast cancer Fung, Teresa T.
2012
132 3 p. 1157-1162
artikel
2 A gene transcription signature of obesity in breast cancer Creighton, Chad J.
2011
132 3 p. 993-1000
artikel
3 A plea for the biopsy marker: how, why and why not clipping after breast biopsy? Thomassin-Naggara, Isabelle
2011
132 3 p. 881-893
artikel
4 Assessing the RNA effect of 26 DNA variants in the BRCA1 and BRCA2 genes Menéndez, Mireia
2011
132 3 p. 979-992
artikel
5 Biopsy sampling of breast lesions: comparison of core needle- and vacuum-assisted breast biopsies Lacambra, Maribel D.
2011
132 3 p. 917-923
artikel
6 CD24 Ala57Val polymorphism predicts pathologic complete response to sequential anthracycline- and taxane-based neoadjuvant chemotherapy for primary breast cancer Marmé, Frederik
2011
132 3 p. 819-831
artikel
7 Characterization of BRCA1 and BRCA2 splicing variants: a collaborative report by ENIGMA consortium members Thomassen, Mads
2011
132 3 p. 1009-1023
artikel
8 Chemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657) Esserman, Laura J.
2011
132 3 p. 1049-1062
artikel
9 Clinical and biomarker predictors of side effects from tamoxifen Lorizio, Wendy
2011
132 3 p. 1107-1118
artikel
10 Co-amplification of the HER2 gene and chromosome 17 centromere: a potential diagnostic pitfall in HER2 testing in breast cancer Varga, Zsuzsanna
2011
132 3 p. 925-935
artikel
11 Comparative gene expression analysis in mouse models for identifying critical pathways in mammary gland development Zhao, Hongbo
2011
132 3 p. 969-977
artikel
12 Different CHEK2 germline mutations are associated with distinct immunophenotypic molecular subtypes of breast cancer Domagala, Pawel
2011
132 3 p. 937-945
artikel
13 Frondoside A inhibits breast cancer metastasis and antagonizes prostaglandin E receptors EP4 and EP2 Ma, Xinrong
2011
132 3 p. 1001-1008
artikel
14 Fruit and vegetables consumption and breast cancer risk: the EPIC Italy study Masala, Giovanna
2012
132 3 p. 1127-1136
artikel
15 Gamma-ray-induced mutagen sensitivity and risk of sporadic breast cancer in young women: a case–control study Wang, Li-E
2012
132 3 p. 1147-1155
artikel
16 Gene expression profiling of breast tumor cell lines to predict for therapeutic response to microtubule-stabilizing agents Kadra, Gais
2011
132 3 p. 1035-1047
artikel
17 Global and focal brain volume in long-term breast cancer survivors exposed to adjuvant chemotherapy Koppelmans, Vincent
2011
132 3 p. 1099-1106
artikel
18 Introduction to special issue Translational goals of neoadjuvant therapy Glück, Stefan
2012
132 3 p. 773
artikel
19 Ipsilateral hemodialysis access after axillary dissection for breast cancer Olsha, Oded
2012
132 3 p. 1173-1176
artikel
20 Ki-67: level of evidence and methodological considerations for its role in the clinical management of breast cancer: analytical and critical review Luporsi, Elisabeth
2011
132 3 p. 895-915
artikel
21 Lack of caveolin-1 (P132L) somatic mutations in breast cancer Ferraldeschi, Roberta
2012
132 3 p. 1185-1186
artikel
22 Locally advanced breast cancers are more likely to present as Interval Cancers: results from the I-SPY 1 TRIAL (CALGB 150007/150012, ACRIN 6657, InterSPORE Trial) Lin, Cheryl
2011
132 3 p. 871-879
artikel
23 Mammographic density, parity and age at first birth, and risk of breast cancer: an analysis of four case–control studies Woolcott, Christy G.
2012
132 3 p. 1163-1171
artikel
24 MDM2 SNP309 and TP53 R72P associated with severe and febrile neutropenia in breast cancer patients treated with 5-FU/epirubicin/cyclophosphamide Okishiro, Masatsugu
2011
132 3 p. 947-953
artikel
25 NQO1 expression correlates inversely with NFκB activation in human breast cancer Jamshidi, Maral
2011
132 3 p. 955-968
artikel
26 Obstetric history and mammographic density: a population-based cross-sectional study in Spain (DDM-Spain) Lope, Virginia
2012
132 3 p. 1137-1146
artikel
27 Pathological complete response rates following different neoadjuvant chemotherapy regimens for operable breast cancer according to ER status, in two parallel, randomized phase II trials with an adaptive study design (ECTO II) Zambetti, Milvia
2011
132 3 p. 843-851
artikel
28 Pathologic complete response after neoadjuvant therapy of breast cancer: pitfalls and shortcomings Minckwitz, Gunter von
2012
132 3 p. 779-780
artikel
29 Phase I–II study of vorinostat plus paclitaxel and bevacizumab in metastatic breast cancer: evidence for vorinostat-induced tubulin acetylation and Hsp90 inhibition in vivo Ramaswamy, B.
2011
132 3 p. 1063-1072
artikel
30 Pilot neoadjuvant trial in HER2 positive breast cancer with combination of nab-paclitaxel and lapatinib Kaklamani, Virginia G.
2011
132 3 p. 833-842
artikel
31 Primary and secondary angiosarcomas of the breast: a single institution experience Fraga-Guedes, Conceição
2011
132 3 p. 1081-1088
artikel
32 RecurrenceOnline: an online analysis tool to determine breast cancer recurrence and hormone receptor status using microarray data Győrffy, Balázs
2011
132 3 p. 1025-1034
artikel
33 Responsiveness of adjacent ductal carcinoma in situ and changes in HER2 status after neoadjuvant chemotherapy/trastuzumab treatment in early breast cancer—results from the GeparQuattro study (GBG 40) Minckwitz, Gunter von
2011
132 3 p. 863-870
artikel
34 SerpinB3, a new prognostic tool in breast cancer patients treated with neoadjuvant chemotherapy Collie-Duguid, Elaina S. R.
2011
132 3 p. 807-818
artikel
35 The efficacy and safety of neoadjuvant chemotherapy +/− letrozole in postmenopausal women with locally advanced breast cancer: a randomized phase III clinical trial Mohammadianpanah, Mohammad
2011
132 3 p. 853-861
artikel
36 The KL-VS sequence variant of Klotho and cancer risk in BRCA1 and BRCA2 mutation carriers Laitman, Yael
2011
132 3 p. 1119-1126
artikel
37 TP53 genomics predict higher clinical and pathologic tumor response in operable early-stage breast cancer treated with docetaxel-capecitabine ± trastuzumab Glück, Stefan
2011
132 3 p. 781-791
artikel
38 Triple-negative breast cancer: the impact of guideline-adherent adjuvant treatment on survival—a retrospective multi-centre cohort study Schwentner, L.
2011
132 3 p. 1073-1080
artikel
39 Tumor-infiltrating lymphocytes are correlated with response to neoadjuvant chemotherapy in triple-negative breast cancer Ono, Makiko
2011
132 3 p. 793-805
artikel
40 US follow-up protocol in concordant benign result after US-guided 14-gauge core needle breast biopsy Youk, Ji Hyun
2012
132 3 p. 1089-1097
artikel
41 Using neoadjuvant therapy for breast cancer in clinical practice: when and how? Tripathy, Debu
2012
132 3 p. 775-777
artikel
42 Why do women accept to undergo a nipple sparing mastectomy or to reconstruct the nipple areola complex when nipple sparing mastectomy is not possible? Didier, F.
2012
132 3 p. 1177-1184
artikel
                             42 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland
Toegankelijkheidsverklaring